
ABSTRACT: For patients who present with ventricular fibrillation (VF) or pulseless ventricular tachycardia that is refractory to repeated countershocks, the drug of choice is amiodarone; the recommended dose for those who are receiving cardiopulmonary resuscitation is 300 mg given as an IV bolus. Vasopressin, 40 U IV, is an acceptable alternative to epinephrine in adults with VF that is resistant to electrical defibrillation. Standard heparin or low molecular weight heparin is indicated in patients who require reperfusion therapy and in those who have unstable angina or non-Q wave myocardial infarction (MI). The initial therapy for patients with acute myocardial ischemia usually includes morphine, oxygen, nitroglycerin, and aspirin, plus a ß-adrenergic blocking agent. Glycoprotein IIb/IIIa receptor inhibitors are currently recommended for patients who have non-Q wave MI or high-risk unstable angina.




























































































































































































































































































































